Exposure to MC-LR in NAFLD conditions significantly altered the expression of Pyruvate kinases (Pklm, Pklr) which were reversed on treatment with targeted antioxidant therapy. Here, PKLR is linked to metabolic dysfunction-associated steatotic liver disease.